Trial Profile
Evaluation of Healing the Biofreedom Stent Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Aug 2017
Price :
$35
*
At a glance
- Drugs Umirolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms EGO-BIOFREEDOM
- 23 Jan 2013 New trial record